At the heart of so many physical and mental health conditions lies the issue of addiction. Opioids, tobacco, and alcohol are just a few of the substances causing both mental suffering and physical harm to patients.
Fortunately, psychedelic medicines have shown much promise in the area of treating addiction, both directly and indirectly – via addressing the trauma that so often lies at the root of addictive patterns.
In the area of direct addiction treatment, we’ve seen promising research from psilocybin for tobacco cessation, MDMA for alcohol use disorder, and ibogaine for opioid use disorder.
So while many health professionals are concerned about recommending psychedelic therapies to their patients for fear that psychedelics are addictive, the truth of the matter is that many of these substances are anti-addictive – so we were very excited to have a panel of guests to help elucidate some of how psychedelic therapies have been shown to help with the challenge of unraveling addiction disorders.
We were honored to have expert panelists on this month’s webinar to cover:
- The research into different psychedelic medicines’ potential in treating addiction disorders
- The role therapy plays in addressing addiction with psychedelic medicines
- How patients prepare for and integrate after psychedelic treatments for addiction
As always, there was ample time for audience Q & A, so make sure you watch to the end!


